BAJAJ BROKING

Notification
No new Notification messages
Stallion India Fluorochemicals IPO is Open!
Apply for the Stallion India Fluorochemicals IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Hamps Bio Limited

Trading

Offer Period :

13th to 17th Dec 2024

Hamps Bio Limited IPO Details

IPO Date 13th to 17th Dec 2024 Minimum Investment ₹102000 / 1 Lots
Listing Date 2024-12-20 Maximum Investment ₹102000 / 1 Lots
Face Value ₹10 per share Total Issue Size ₹6.22 Crores
Price ₹51 to ₹51 per share Fresh Issue ₹6.22 Crores
Lot Size 1 Lots (2000 Shares) Offer For Sale ₹ 0
Listing At BSE-SME Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date 13th to 17th Dec 2024
Listing Date 2024-12-20
Face Value ₹10 per share
Price ₹51 to ₹51 per share
Lot Size 1 Lots (2000 Shares)
Listing At BSE-SME
Employee Discount ₹0 per share
Minimum Investment ₹102000 / 1 Lots
Maximum Investment ₹102000 / 1 Lots
Total Issue Size ₹6.22 Crores
Fresh Issue ₹6.22 Crores
Offer For Sale
Retail Discount ₹ 0

About Hamps Bio Limited

Established in 2007, Hamps Bio Limited specializes in marketing and distributing pharmaceutical products, including tablets, syrups, capsules, injectables, oils, and nutritional supplements. The company operates a robust distribution network of over 50 distributors and e-commerce platforms like Amazon (US, Canada, EU), Flipkart, and Jio Mart. Its pharmaceutical offerings, branded under "Hamps," are available in 8 states and union territories, while its freeze-dried and frozen products reach 6 countries and 22 states and union territories.

Hamps Bio’s business is divided into two key segments: Pharmaceuticals and FMCG. The pharmaceutical division focuses on a range of medical products, while its FMCG segment, under the "FzyEzy" brand, offers freeze-dried and frozen items such as strawberry, mango, and beet powders. With over 180 products across both segments and a presence in both B2B and B2C models, the company leverages its strong brand identity, diverse product range, and expansive global reach to drive growth.

Timeline

Important dates for allocation and IPO listing.

13th Dec

IPO Starts

17th Dec

IPO Ends

18th Dec

Allotment Date

19th Dec

Initiation of Refund

19th Dec

Credit of Shares to Demat Account

20th Dec

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 100 71.99
Public Group 0 28.01

Hamps Bio Limited IPO Reservation

QIB Shares Offered 0(0%)
NII (HNI) Shares Offered 578000(47.38%)
Retail Shares Offered 580000(47.54%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 1220000
Total Shares With Anchor Investor 1220000

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Hamps Bio Limited IPO Registrar

Bigshare Services Pvt Ltd
Phone Number 022 - 6263 8200
Email Id investor@bigshareonline.com
Our Website www.bigshareonline.com

Hamps Bio Limited IPO Lead Manager

1. Marwadi Chandarana Intermediaries Brokers Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Hamps Bio Limited IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Non Institutional Investors 6,41,000 3,54,58,000 5,450.0
Retail Individual Investors (RIIs) 5,79,000 22,50,70,000 1,12,535.0
Total 12,20,001 26,05,72,000 1,88,803.0

Strength of Hamps Bio Limited

1. Expert Leadership and Industry Experience driving Strategic Business Growth.

2. Distribution Network with Expansive E-Retailing Presence.

3. Wide and diversified range of products.

4. Diversified, global customer base with long standing relationships.

5. Wide Geographical Presence.

6. Brand Identity.

7. Quality Assurance.

Risks Involved

1. The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.

2. The company does not have its own manufacturing facility for pharmaceutical products and the company has to relies on third parties for procuring pharmaceutical products sold by the Company.

3. Its existing manufacturing facility for freeze dried and frozen products is concentrated in a single region i.e., Ankelshwar, Gujarat and the inability to operate and grow its business in this particular region may have an adverse effect on its business, financial condition, results of operations, cash flows and future business prospects.

4. The company operates in a highly regulated and controlled industry environment. The Company operates under several statutory and regulatory permits, licenses and approvals. The company failures to obtain and/or renew any approvals or licenses in future may have an adverse impact on its business operations.

5. The company failures to comply with applicable quality standards may result in product liability claims, which could adversely affect its business, financial condition, cash flows and results of operations.

6. The availability of counterfeit drugs, such as those passed off by others as its products, and the introduction of alternative pharmaceutical products due to changes in technology or consumer needs, could adversely affect its goodwill, results of operations, financial results, and business prospects.

7. Any disruptions to the supply, or increases in the pricing, of the raw materials and finished products that the company outsource, may adversely affect the supply and pricing of its products and, in turn, adversely affect the company business, cash flows, financial condition and results of operations.

8. Its Group Companies has incurred losses in past financial years.

9. The Company had negative cash flows in the past years, details of which are given below. Sustained negative cash flow could impact its growth and business.

10. The company is dependent upon few suppliers for the material requirements of its Freeze dried and Frozen Products business. Further, the company does not have definitive agreements or fixed terms of trade with most of its suppliers. Failures to successfully leverage the company relationships with existing suppliers or to identify new suppliers could adversely affect its business operations.

Industry Outlook of Hamps Bio IPO

  • Pharmaceutical Industry Growth: The Indian pharmaceutical market is projected to grow at a CAGR of 10-12% over the next five years, driven by increasing healthcare awareness, government initiatives, and export opportunities.
  • Demand for Freeze-Dried Products: The freeze-dried food segment, where Hamps Bio operates through its FMCG division, is seeing rising demand due to its convenience, long shelf life, and nutritional value.
  • Expanding E-commerce Market: With the increasing penetration of e-commerce platforms, companies like Hamps Bio benefit from a broader reach, leveraging platforms like Amazon and Flipkart for distribution.
  • Favorable Government Policies: Policies like 'Make in India' and Production Linked Incentive (PLI) schemes for pharmaceuticals are enhancing manufacturing capabilities, creating opportunities for growth in both domestic and export markets.
  • Growing FMCG Sector: The Indian FMCG market is expanding due to increasing disposable income and urbanization, creating a favorable environment for companies in the freeze-dried food segment.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
 
Total Assets
Total Liabilities
Total Expenses
Total Revenue 
Profit After Tax
EBITDA
Adjusted EBITDA

Hamps Bio Limited IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2024-12-20 544312 -
INE0QBD01018
₹51 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹51 ₹51
Open ₹96.9 ₹0
Low ₹96.9 ₹0
High ₹101.74 ₹0
Low ₹96.9 ₹0

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Hamps Bio IPO.

Frequently Asked Questions

What is Hamps Bio Limited IPO?

Answer Field

Hamps Bio Limited IPO is a SME IPO of 12,20,000 equity shares of a face value of ₹10 aggregating up to ₹6.22 Crores. The issue is priced at ₹51 to ₹51 per share. The minimum order quantity is 2000 Shares. The IPO opens on December 13, 2024, and closes on December 17, 2024. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE-SME.

When Hamps Bio Limited IPO will open?

Answer Field

The Hamps Bio Limited IPO opens on December 13, 2024 and closes on December 17, 2024.

What is the lot size of Hamps Bio Limited?

Answer Field

Hamps Bio Limited lot size is 2000 shares, and the minimum amount required is ₹1,02,000.

How to apply for Hamps Bio Limited IPO?

Answer Field

You can apply in Hamps Bio Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Hamps Bio Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Hamps Bio Limited IPO will be done on December 18, 2024, and the allotted shares will be credited to your demat account by December 19, 2024.

When is Hamps Bio Limited IPO listing date?

Answer Field

The Hamps Bio Limited listing date is December 20, 2024.

Who is the registrar of Hamps Bio Limited IPO?

Answer Field

The registrar of Hamps Bio Limited IPO is Bigshare Services Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Marwadi Chandarana Intermediaries Brokers Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Hamps Bio Limited IPO?

Answer Field

The fresh issue size is ₹6.22 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Hamps Bio Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, 2000 shares and ₹1,02,000 amount.

How can I approve the UPI mandate request for Hamps Bio Limited IPO?

Answer Field

To apply for Hamps Bio Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Hamps Bio Limited?

Answer Field

The price of each Hamps Bio Limited share will be ranging in between ₹51 to ₹51 per share.

What is the cut-off time for the UPI mandate for Hamps Bio Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, December 17, 2024.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • BARFLEX POLYFILMS LIMITEDSME IPO

  • Bidding Dates

    10th Jan 2025 - 1st Jan 2025

  • Price Range

    ₹57.0 - 60.0

  • IPO Size

    ₹39,42,00,000

  • Apply Now
  • LAXMI DENTAL LIMITEDMainboard IPO

  • Bidding Dates

    13th Jan 2025 - 1st Jan 2025

  • Price Range

    ₹407.0 - 428.0

  • IPO Size

    ₹6,98,06,00,000

  • Apply Now
  • KABRA JEWELS LIMITEDSME IPO

  • Bidding Dates

    15th Jan 2025 - 1st Jan 2025

  • Price Range

    ₹121.0 - 128.0

  • IPO Size

    ₹40,00,00,000

  • Apply Now
  • RIKHAV SECURITIES LIMITEDSME IPO

  • Bidding Dates

    15th Jan 2025 - 1st Jan 2025

  • Price Range

    ₹82.0 - 86.0

  • IPO Size

    ₹88,82,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • CARRARO INDIA LIMITEDMainboard IPO

  • Issue Price

    704.00

  • Listing Day Close

    636.30

  • Listing Day (Gain/Loss)

    -9.66

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5300+ Cr MTF Book

icon-with-text